Contact

Let’s expand radionuclide production

We welcome conversations with cyclotron operators, radioisotope producers, CDMOs, radiopharmaceutical developers, organizations with access to Ra‑226, and groups exploring neutron‑produced medical radionuclides. EnVoy’s primary focus is high‑yield Ac‑225 and Pb‑212 production on 19⁠–⁠30 MeV cyclotrons, with additional radionuclide‑production opportunities beginning at 16 MeV.